Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nicotinic receptor antagonists and pioglitazone as therapeutic agents for Covid-19

Nicotinic receptor antagonists and pioglitazone as therapeutic agents for Covid-19

US Patent 11766429 · Granted Sep 26, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods of deep learning for colorectal polyp screening2025
Systems and methods of deep learning for colorectal polyp screening2025
Exosomes isolated from mesenchymal stem cells and uses thereof2025
Exosomes isolated from mesenchymal stem cells and uses thereof2025
Ultrafast-UV laser integrating cavity mediated inactivation of a pathogen2025
Ultrafast-UV laser integrating cavity mediated inactivation of a pathogen2025
Plasma derived from human umbilical cord blood for the treatment of neurodegener2024
Methods of using protein palmitoylations inhibitors2024
Microparticle compositions for controlled delivery of telmisartan and actinomyci2024
Microparticle compositions for controlled delivery of telmisartan and actinomyci2024
Compositions and methods for treating RSV-infections2024
Compositions and methods for treating RSV-infections2024